Core Viewpoint - Jinxin Fertility (01951) announced a share buyback plan, intending to repurchase 4.825 million shares for a total cost of HKD 12.121 million [1] Group 1 - The company will execute the buyback on December 17, 2025 [1] - The total number of shares to be repurchased is 4.825 million [1] - The total expenditure for the buyback is HKD 12.121 million [1]

| 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01951 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 | | 於下列日期開始時的結存(註1) | 2025年12月15日 | | 2,744,706,043 | | 13,000,000 | | 2,757,706,043 | | 1). 其他 (請註明) | | | | % | | | | | 見B部分 | | | | | | | | | 變動日期 | 2025年12月17日 | | | | | ...

证券之星消息，12月16日，深港通医疗(港币)（983036）指数报收于4264.99点，跌0.54%，成交79.31亿 元，换手率0.81%。当日该指数成份股中，上涨的有17家，福瑞股份以4.6%的涨幅领涨，下跌的有41 家，健康之路以5.81%的跌幅领跌。 深港通医疗(港币)（983036）指数十大成份股详情如下： | 深港通医疗(港币)指数 十大成份股 | | --- | | 证券代码 | 股票简称 | 权重 | 最新价 | 涨跌幅 | 总市值(亿元) | 所属行业 | | --- | --- | --- | --- | --- | --- | --- | | hk02587 | 健康之路 | | 3.97 | -5.81% | 34.85 | 计算机 | | hk02522 | 一脉阳光 | i | 8.23 | -4.93% | 32.59 | 医药生物 | | hk06086 | 方丹健客 | | 2.48 | -4.55% | 33.20 | 医药生物 | | sz301584 | 建发致新 | -- | 31.07 | -3.87% | 130.89 | 医药生物 | | hk02609 | ...

Core Insights - The article discusses the stock buyback activities of various companies, highlighting the total amounts and quantities repurchased, with Tencent Holdings leading the buyback efforts [1][2]. Group 1: Buyback Overview - Tencent Holdings (00700) repurchased 1.051 million shares for a total of 636 million, representing 0.995% of its total share capital [2]. - Xiaomi Group (01810) repurchased 7.2 million shares for 302 million, accounting for 0.430% of its total share capital [2]. - China COSCO Shipping Holdings (01919) repurchased 2.95 million shares for 40.016 million, which is 3.089% of its total share capital [2]. Group 2: Notable Buybacks - Kuaishou Technology (01024) repurchased 462,000 shares for 29.9304 million, representing 0.191% of its total share capital [2]. - Kingsoft Corporation (03888) repurchased 702,800 shares for 19.9994 million, which is 0.580% of its total share capital [2]. - Country Garden Services (06098) repurchased 3 million shares for 18.9615 million, accounting for 1.284% of its total share capital [2]. Group 3: Other Companies - Coolpad Group (02369) repurchased 3.16 million shares for 4.1717 million, representing 7.986% of its total share capital [2]. - China Petroleum & Chemical Corporation (00386) repurchased 764,000 shares for 3.306 million, which is 0.190% of its total share capital [2]. - Mengniu Dairy (02319) repurchased 200,000 shares for 2.9675 million, accounting for 0.762% of its total share capital [2].

Group 1 - The company, Jinxin Reproductive Medicine (01951), announced a share buyback plan on December 15, 2025, with an investment of HKD 9.939 million to repurchase 3.891 million shares [1]

Group 1 - The company, Jinxin Reproductive Medicine (01951), announced a share buyback plan on December 15, 2025, involving an expenditure of HKD 9.939 million to repurchase 3.891 million shares [1]

Group 1 - The company, Jinxin Reproductive Medicine (01951.HK), announced a share buyback on December 15, spending HKD 9.939 million to repurchase 3.891 million shares [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 錦欣生殖醫療集團有限公司 呈交日期： 2025年12月15日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01951 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（ ...

Group 1 - The stock price of Jinxin Reproductive Medicine (01951) increased by 1.99% to HKD 2.56, with a trading volume of HKD 66.02 million [2][5] - The National Medical Security Work Conference held on December 13 emphasized the need to adapt to population development strategies and promote the development of maternity insurance and long-term care insurance [2][5] - By 2025, all 31 provinces and regions, including Xinjiang Production and Construction Corps, are expected to include eligible assisted reproductive projects in medical insurance, with 7 provinces achieving full coverage of hospitalization costs for childbirth [2][5] Group 2 - Jinxin Reproductive Medicine announced a share buyback plan with a total price of no less than HKD 100 million, having repurchased 23.224 million shares for HKD 57.717 million last week [2][5] - As of now, the company has completed the buyback of 30.946 million shares this month, totaling HKD 77.515 million [2][5] - The company aims to focus on improving operational performance and enhancing intrinsic value to create sustainable returns for shareholders [2][5]

Core Viewpoint - The Hong Kong stock market saw a rise in three-child policy concept stocks, driven by a recent national medical insurance conference that outlined plans to enhance maternity insurance and support for various employment groups [1] Group 1: Policy Impact - The national medical insurance conference emphasized the need to adapt to population development strategies by promoting maternity insurance and long-term care insurance by 2026 [1] - The policy aims to include flexible workers, migrant workers, and new employment forms in maternity insurance coverage [1] - There is a goal to improve the medical expense coverage for prenatal checks, aiming for "no out-of-pocket" expenses for childbirth within the policy scope nationwide [1] Group 2: Market Reaction - Stocks related to assisted reproduction and maternal and child healthcare sectors reacted positively, with companies like Jinxin Fertility rising approximately 4% [1] - Other companies such as China Feihe, Mengniu Dairy, and China Wangwang also experienced gains of 2%, 1.4%, and 0.21% respectively [2]